SCHEMBL24310454

SCHEMBL24310454

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Cl)c1CC(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.31
▸ RORC P51449 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309815 0.86 JAK2 (0.34) JAK2
SCHEMBL24310486 0.85 JAK2 (0.32) JAK2
SCHEMBL24309836 0.84 JAK2 (0.33) JAK2
SCHEMBL24309723 0.84 JAK2 (0.34) JAK2
SCHEMBL24309576 0.82 JAK2 (0.33) JAK2
SCHEMBL24309833 0.82 JAK2 (0.32) JAK2
SCHEMBL24309404 0.82 CNR1 (0.35) JAK2
SCHEMBL24310692 0.81 JAK2 (0.33) JAK2
SCHEMBL24309978 0.80 HTR1A (0.35) JAK2
SCHEMBL24309390 0.78 JAK2 (0.31) JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback